Addus Homecare Corp
NASDAQ:ADUS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
86.6
133.58
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Addus Homecare Corp
Wall Street
Price Targets
ADUS Price Targets Summary
Addus Homecare Corp
According to Wall Street analysts, the average 1-year price target for
ADUS
is 142.43 USD
with a low forecast of 83.83 USD and a high forecast of 168 USD.
ADUS Last Price Targets
Addus Homecare Corp
The latest public price target was made on Nov 6, 2024 by
Scott Fidel
from
Stephens
,
who expects
ADUS
stock to
rise by 11%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Scott Fidel
Stephens
|
145
USD
Upside 11% |
1 month ago
Nov 6, 2024
|
Addus HomeCare (ADUS) PT Raised to $145 at Stephens
StreetInsider
|
Matthew Gillmor
KeyBanc
|
150
USD
Upside 15% |
2 months ago
Oct 10, 2024
|
Addus HomeCare initiated with an Overweight at KeyBanc
TheFly
|
Michael Wiederhorn
Oppenheimer
|
145
USD
Upside 11% |
3 months ago
Sep 23, 2024
|
Addus HomeCare (ADUS) PT Raised to $145 at Oppenheimer
StreetInsider
|
Frank Morgan
RBC Capital
|
141
USD
Upside 8% |
4 months ago
Aug 8, 2024
|
Addus HomeCare (ADUS) PT Raised to $141 at RBC Capital
StreetInsider
|
|
Michael Wiederhorn
Oppenheimer
|
140
USD
Upside 8% |
4 months ago
Aug 7, 2024
|
Addus HomeCare (ADUS) PT Raised to $140 at Oppenheimer
StreetInsider
|
|
Michael Wiederhorn
Oppenheimer
|
130
USD
Downside 0% |
6 months ago
Jun 7, 2024
|
Addus HomeCare (ADUS) PT Raised to $130 at Oppenheimer
StreetInsider
|
|
Scott Fidel
Stephens
|
128
USD
Downside 2% |
6 months ago
May 31, 2024
|
Addus HomeCare (ADUS) PT Raised to $128 at Stephens
StreetInsider
|
|
Frank Morgan
RBC Capital
|
129
USD
Downside 1% |
6 months ago
May 28, 2024
|
Addus HomeCare (ADUS) PT Raised to $129 at RBC Capital
StreetInsider
|
Andrew Mok
Barclays
|
83
USD
Downside 36% |
8 months ago
Apr 23, 2024
|
Barclays downgrades Addus to Underweight on 'materially negative' regulation
TheFly
|
|
Scott Fidel
Stephens
|
115
USD
Downside 12% |
8 months ago
Apr 1, 2024
|
Addus HomeCare price target raised to $115 from $110 at Stephens
TheFly
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ADUS's stock price target?
Price Target
142.43
USD
According to Wall Street analysts, the average 1-year price target for
ADUS
is 142.43 USD
with a low forecast of 83.83 USD and a high forecast of 168 USD.
What is Addus Homecare Corp's Revenue forecast?
Projected CAGR
14%
For the last 8 years the
compound annual growth rate for
Addus Homecare Corp's revenue is
15%.
The projected
CAGR
for the next 3 years is
14%.
What is Addus Homecare Corp's Operating Income forecast?
Projected CAGR
21%
For the last 8 years the
compound annual growth rate for
Addus Homecare Corp's operating income is
24%.
The projected
CAGR
for the next 3 years is
21%.
What is Addus Homecare Corp's Net Income forecast?
Projected CAGR
26%
For the last 8 years the
compound annual growth rate for
Addus Homecare Corp's net income is
23%.
The projected
CAGR
for the next 3 years is
26%.
You don't have any saved screeners yet
